Abstract Body

Background: Achieving a cure for HIV will require both the complete suppression of active viral replication and the clearance of the transcriptionally silent proviral latent reservoir. Current drug treatments effectively target the active virus but leave the latent reservoir intact. We describe a cellular pathway involving miR-155 and one of its many cellular targets, TRIM32, that appears to promote a return to latency in reservoir cells transiently producing virus.

Methods: We first assessed whether miRNAs play a role in maintenance of viral latency by separately knocking down the expression of two of the major enzymes involved in miRNA biogenesis, DGCR8 and Dicer, in J-Lat 5A8 cells. We next used miRNA TLDA analysis to identify specific miRNAs that alter the level of reactivation following stimulation. We focused on miR-155 because its reintroduction into Dicer-deficient cells was able to rescue the level of latent reactivation in J-Lat 5A8 cells to the greatest extent, suggesting that it plays a prominent role in reinforcing HIV latency. We confirmed TRIM32 as a novel target of miR-155 using luciferase binding assays. An IkB kinase (IKK) kinase assay revealed that TRIM32 acts downstream of the IKKs. Finally, our in vitro ubiquitination assays demonstrate that TRIM32 is able to directly ubiquitinate IκBα.

Results: MiR-155, which is expressed at high levels in activated cells, impairs the expression of TRIM32, which normally serves as an HIV-activating agent. TRIM32 activates latent HIV by stimulating nuclear translocation of NF-κB. However, our studies reveal that TRIM32 activates NF-κB in a novel manner involving direct ubiquitination of IκBα. Specifically, TRIM32 induction of NF-κB proceeds independently of IKK activation within signalosomes.

Conclusions: Our studies of the potential role of microRNAs in the regulation of HIV latency have led to the identification of miR-155 and its inhibition of TRIM32 activation of NF-κB as events that promote the reestablishment of HIV latency in reservoir cells undergoing transient viral production.